Selecting an e-cigarette for use in smoking cessation interventions and healthcare services: Findings from patient and public consultation for the COSTED trial

Belderson, Pippa, Ward, Emma ORCID: https://orcid.org/0000-0002-7579-3215, Pope, Ian ORCID: https://orcid.org/0000-0002-5623-4178 and Notley, Caitlin ORCID: https://orcid.org/0000-0003-0876-3304 (2024) Selecting an e-cigarette for use in smoking cessation interventions and healthcare services: Findings from patient and public consultation for the COSTED trial. BMJ Open, 14 (3). ISSN 2044-6055

[thumbnail of Belderson_etal_2024_BMJOpen]
Preview
PDF (Belderson_etal_2024_BMJOpen) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview

Abstract

Objectives The Cessation of Smoking Trial in the Emergency Department (COSTED) trial aims to ascertain whether brief advice, the provision of an e-cigarette starter kit and referral to stop smoking services (SSS), increases smoking cessation in people attending the emergency department. Patient and public involvement (PPI) and scoping work were undertaken to select an appropriate e-cigarette for the trial. Design and setting PPI consultation and feasibility scoping about potential devices with a professional and lay panel, all based in England. Consultation was via email, telephone or video interview. This work took place between April and July 2021, prior to recruitment commencing for the COSTED trial. Participants A professional panel (n=7) including representatives from academia, SSS and the independent vaping industry, and a PPI lay panel (n=3) who smoke or vape. Results The professional panel recommended a shortlist of devices which were tested by the PPI lay panel. Key criteria for selecting an appropriate e-cigarette for smoking cessation intervention include satisfaction, usability, affordability and availability. Simplicity of use was highlighted by the PPI lay panel, who found refillable devices complex, and availability of consumables was highlighted as more important than price by both panels. The pod device selected for inclusion was rated highly for satisfaction and usability and had mid-price range and consumables which were widely available. Conclusions To select the most appropriate device for the COSTED trial, each criterion required assessment to ensure the best fit to the intervention context and needs of the target population. There is a need for guidance to help enable decision-making about choice of vape products, tailored to service users’ needs. We propose a bespoke checklist template, based on our findings, to assist with this process. This has applicability to the recent government announcement of a ‘Swap to Stop’ programme, offering a vaping starter kit to smokers across England, allowing services flexibility to shape their own programmes and models of delivery. Trial registration number Clinical trial number NCT04854616; pre-results.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups: Faculty of Social Sciences > Research Centres > Centre for Research on Children and Families
Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging
Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Depositing User: LivePure Connector
Date Deposited: 04 Mar 2024 18:31
Last Modified: 08 Mar 2024 12:33
URI: https://ueaeprints.uea.ac.uk/id/eprint/94484
DOI: 10.1136/bmjopen-2023-078677

Actions (login required)

View Item View Item